no code implementations • 19 Oct 2024 • Gesa Mittmann, Sara Laiouar-Pedari, Hendrik A. Mehrtens, Sarah Haggenmüller, Tabea-Clara Bucher, Tirtha Chanda, Nadine T. Gaisa, Mathias Wagner, Gilbert Georg Klamminger, Tilman T. Rau, Christina Neppl, Eva Maria Compérat, Andreas Gocht, Monika Hämmerle, Niels J. Rupp, Jula Westhoff, Irene Krücken, Maximillian Seidl, Christian M. Schürch, Marcus Bauer, Wiebke Solass, Yu Chun Tam, Florian Weber, Rainer Grobholz, Jaroslaw Augustyniak, Thomas Kalinski, Christian Hörner, Kirsten D. Mertz, Constanze Döring, Andreas Erbersdobler, Gabriele Deubler, Felix Bremmer, Ulrich Sommer, Michael Brodhun, Jon Griffin, Maria Sarah L. Lenon, Kiril Trpkov, Liang Cheng, Fei Chen, Angelique Levi, Guoping Cai, Tri Q. Nguyen, Ali Amin, Alessia Cimadamore, Ahmed Shabaik, Varsha Manucha, Nazeel Ahmad, Nidia Messias, Francesca Sanguedolce, Diana Taheri, Ezra Baraban, Liwei Jia, Rajal B. Shah, Farshid Siadat, Nicole Swarbrick, Kyung Park, Oudai Hassan, Siamak Sakhaie, Michelle R. Downes, Hiroshi Miyamoto, Sean R. Williamson, Tim Holland-Letz, Carolin V. Schneider, Jakob Nikolas Kather, Yuri Tolkach, Titus J. Brinker
The aggressiveness of prostate cancer, the most common cancer in men worldwide, is primarily assessed based on histopathological data using the Gleason scoring system.
1 code implementation • 8 Mar 2023 • Lisa M. Koch, Christian M. Schürch, Christian F. Baumgartner, Arthur Gretton, Philipp Berens
We formulate subgroup shift detection in the framework of statistical hypothesis testing and show that recent state-of-the-art statistical tests can be effectively applied to subgroup shift detection on medical imaging data.
no code implementations • 6 Feb 2023 • Martin Paulikat, Christian M. Schürch, Christian F. Baumgartner
HMTI technologies can be used to gain insights into the iTME and in particular how the iTME differs for different patient outcome groups of interest (e. g., treatment responders vs. non-responders).